Director/PDMR Share Dealing

RNS Number : 7592I
Provident Financial PLC
03 April 2020
 

Provident Financial plc ("the Company")

Director/PDMR Transaction - Initial Notification

 

The Company announces that it has granted the following awards over the Company's ordinary shares of 20 8/11p as follows:

 

1.  on 1 April 2020, the Company granted a conditional award over 248,733 ordinary shares of 20 8/11p for no consideration to Neeraj Kapur who is a Director of the Company under the Provident Financial Long Term Incentive Scheme 2015 (the "LTIS Awards"); and

 

2.  on 2 April 2020 the Company also granted conditional awards over a total of 175,662 ordinary shares of 20 8/11p for no consideration to Neeraj Kapur. The conditional award will normally vest, subject to continued service and performance conditions, as follows:

 

· 34,265 ordinary shares of 20 8/11p will vest on 20 April 2021

· 50,540 ordinary shares of 20 8/11p will vest on 1 April 2022

· 23,830 ordinary shares of 20 8/11p will vest on 20 April 2022

· 67,027 ordinary shares of 20 8/11p will vest on 2 April 2023

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Neeraj Kapur

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Finance Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Provident Financial plc

b)

 

LEI

 

213800U93SZC44VXN635

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 20 8/11p

 

GB00B1Z4ST84

 

 

b)

 

Nature of the transaction

 

Acquisition of a conditional award under the Provident Financial Long Term Incentive Scheme 2015

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£2.17

248,733

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

248,733

 

£540,000

e)

 

Date of the transaction

1 April 2020

f)

 

Place of the transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Neeraj Kapur

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Finance Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Provident Financial plc

b)

 

LEI

 

213800U93SZC44VXN635

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 20 8/11p

 

GB00B1Z4ST84

 

 

b)

 

Nature of the transaction

 

Grant of a conditional award by the Company over 175,662 shares under a Buy Out Award Agreement.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£1.85

175,662

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

175,662

 

£324,978

e)

 

Date of the transaction

2 April 2020

f)

 

Place of the transaction

Outside a trading venue

 

 

Name of authorised official of issuer responsible for making notification:

David Whincup, Deputy Company Secretary

Date of Notification :

3 April 2020


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBGGDSRXGDGGX
UK 100